-
BCRX Dashboard
- Financials
- Filings
-
Holdings
- Transcripts
- ETFs
- Insider
- Institutional
- Shorts
BioCryst Pharmaceuticals (BCRX)
Company Profile
Quarter (USD) | Dec 24 | Sep 24 | Jun 24 | Mar 24 | |
---|---|---|---|---|---|
Revenue | |||||
Cost of revenue | |||||
Operating income | |||||
Operating margin | |||||
Net income | |||||
Net profit margin | |||||
Cash on hand | |||||
Change in cash | |||||
Diluted EPS |
Annual (USD) | Dec 24 | Dec 23 | Dec 22 | Dec 21 | |
---|---|---|---|---|---|
Revenue | |||||
Cost of revenue | |||||
Operating income | |||||
Operating margin | |||||
Net income | |||||
Net profit margin | |||||
Cash on hand | |||||
Change in cash | |||||
Diluted EPS |
Cash burn rate (est.) | Burn method: Change in cash | Burn method: Operating income | Burn method: FCF (opex + capex) | Last Q | Avg 4Q | Last Q | Avg 4Q | Last Q | Avg 4Q |
---|---|---|---|---|---|---|
Cash on hand (at last report) | 106.32 mm | 106.32 mm | 106.32 mm | 106.32 mm | 106.32 mm | 106.32 mm |
Cash burn (monthly) | (no burn) | 510.33 k | 8.66 mm | 7.25 mm | 1.74 mm | 4.34 mm |
Cash used (since last report) | n/a | 1.06 mm | 17.95 mm | 15.01 mm | 3.60 mm | 8.98 mm |
Cash remaining | n/a | 105.27 mm | 88.37 mm | 91.31 mm | 102.72 mm | 97.34 mm |
Runway (months of cash) | n/a | 206.3 | 10.2 | 12.6 | 59.1 | 22.5 |
13F holders | Current |
---|---|
Total holders | 254 |
Opened positions | 35 |
Closed positions | 37 |
Increased positions | 79 |
Reduced positions | 90 |
13F shares | Current |
---|---|
Total value | 1.22 tn |
Total shares | 167.80 mm |
Total puts | 989.40 k |
Total calls | 728.20 k |
Total put/call ratio | 1.4 |
Largest owners | Shares | Value |
---|---|---|
BlackRock | 22.10 mm | $166.16 bn |
Vanguard | 21.89 mm | $164.62 bn |
Avoro Capital Advisors | 11.87 mm | $89.22 bn |
Kynam Capital Management | 9.09 mm | $68.32 bn |
Deerfield Management | 8.14 mm | $61.25 bn |
STT State Street | 7.50 mm | $56.39 bn |
Alkeon Capital Management | 7.09 mm | $53.35 bn |
Geode Capital Management | 4.82 mm | $36.28 bn |
RP Management | 3.85 mm | $29.23 bn |
Nuveen Asset Management | 3.42 mm | $25.71 bn |
Date | Owner | Security | Transaction | Code | Indirect | 10b5-1 | $Price | #Shares | $Value | #Remaining |
---|---|---|---|---|---|---|---|---|---|---|
20 Dec 24 | Stonehouse Jon P | Common Stock | Gift | Acquire G | Yes | No | 0 | 10,000 | 0.00 | 30,000 |
20 Dec 24 | Stonehouse Jon P | Common Stock | Gift | Acquire G | Yes | No | 0 | 10,000 | 0.00 | 30,000 |
20 Dec 24 | Stonehouse Jon P | Common Stock | Gift | Dispose G | No | No | 0 | 20,000 | 0.00 | 1,429,109 |
19 Dec 24 | Stonehouse Jon P | Common Stock | Payment of exercise | Dispose F | No | No | 7.39 | 14,010 | 103.53 k | 1,449,109 |
19 Dec 24 | Stonehouse Jon P | Common Stock | Grant | Acquire A | No | No | 0 | 362,100 | 0.00 | 1,463,119 |
19 Dec 24 | Stonehouse Jon P | Emp. Stock Option Common Stock | Grant | Acquire A | No | No | 7.39 | 750,250 | 5.54 mm | 750,250 |
19 Dec 24 | Anthony Doyle | Common Stock | Payment of exercise | Dispose F | No | No | 7.39 | 2,461 | 18.19 k | 377,867 |
19 Dec 24 | Anthony Doyle | Common Stock | Grant | Acquire A | No | No | 0 | 120,700 | 0.00 | 380,328 |
19 Dec 24 | Anthony Doyle | Emp. Stock Option Common Stock | Grant | Acquire A | No | No | 7.39 | 250,100 | 1.85 mm | 250,100 |
19 Dec 24 | Alane P Barnes | Common Stock | Payment of exercise | Dispose F | No | No | 7.39 | 2,461 | 18.19 k | 412,729 |